UBE3A and Angelman syndrome: Moreover, the use of AntagoNATto suppressed the gene UBE3A-AS, which is known to suppress the paternal copy of the ubiquitin protein ligase E3A gene (UBE3A), which improves cognitive deficits of the Angelman Syndrome in mice model (Meng et al., 2015).